IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,281,500 | -4.2% | 9,500,000 | 0.0% | 0.05% | 0.0% |
Q2 2023 | $9,684,775 | +2.0% | 9,500,000 | 0.0% | 0.05% | +4.3% |
Q1 2023 | $9,495,440 | -9.0% | 9,500,000 | 0.0% | 0.05% | -6.1% |
Q4 2022 | $10,437,460 | +7.4% | 9,500,000 | 0.0% | 0.05% | +11.4% |
Q3 2022 | $9,722,000 | -4.8% | 9,500,000 | 0.0% | 0.04% | 0.0% |
Q2 2022 | $10,215,000 | -9.4% | 9,500,000 | 0.0% | 0.04% | +4.8% |
Q1 2022 | $11,276,000 | +4.0% | 9,500,000 | 0.0% | 0.04% | +2.4% |
Q4 2021 | $10,840,000 | -5.6% | 9,500,000 | 0.0% | 0.04% | -18.0% |
Q3 2021 | $11,484,000 | +0.8% | 9,500,000 | 0.0% | 0.05% | -3.8% |
Q2 2021 | $11,397,000 | +6.0% | 9,500,000 | 0.0% | 0.05% | -11.9% |
Q1 2021 | $10,748,000 | +0.6% | 9,500,000 | 0.0% | 0.06% | -4.8% |
Q4 2020 | $10,688,000 | +13.7% | 9,500,000 | 0.0% | 0.06% | +1.6% |
Q3 2020 | $9,404,000 | – | 9,500,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 69,285,732 | $54,302,494 | 2.70% |
CAMDEN ASSET MANAGEMENT L P /CA | 50,071,000 | $48,664,005 | 1.81% |
Boussard & Gavaudan Investment Management LLP | 6,577 | $6,483,091 | 0.76% |
READYSTATE ASSET MANAGEMENT LP | 12,000,000 | $11,722,800 | 0.59% |
BRAIDWELL LP | 15,500,000 | $15,141,950 | 0.48% |
WOLVERINE ASSET MANAGEMENT LLC | 39,174,000 | $38,348,717 | 0.43% |
CSS LLC/IL | 5,500,000 | $5,379,280 | 0.35% |
SHENKMAN CAPITAL MANAGEMENT INC | 3,239,000 | $3,239,825 | 0.24% |
CAPSTONE INVESTMENT ADVISORS, LLC | 15,174,000 | $14,823,481 | 0.07% |
Calamos Advisors LLC | 9,500,000 | $9,281,500 | 0.05% |